| View |
|
DRP-13209-02
|
Pregabalin
|
None
|
75 mg
|
Capsule
|
Antiepileptic
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
29 December 2027
|
| View |
|
DRP-13229-10
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Curasit
|
50 mg / 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
17 March 2024
|
05 January 2028
|
| View |
|
DRP-13229-11
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Co-Zincretin 50/ 500
|
50 mg / 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
05 January 2028
|
| View |
|
DRP-13230-06
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Co-Zincretin XR 100/1000
|
100 mg/ 1g
|
Extended Release Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
05 January 2028
|
| View |
|
DRP-13230-07
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Forglip
|
100 mg/1g
|
Extended Release Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 March 2024
|
05 January 2028
|
| View |
|
DRP-1326-04
|
Cefuroxime (as sodium)
|
Cefudime
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
Automatic Renewal
|
29 March 2024
|
24 March 2029
|
| View |
|
DRP-13319-02
|
Aluminum Hydroxide + Magnesium Hydroxide + Oxetacaine
|
Tricid-S
|
582 mg/196 mg/20 mg per 10 mL
|
Oral Suspension
|
Antacid
|
Daewon Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
24 March 2024
|
26 January 2028
|
| View |
|
DRP-13355-01
|
Vildagliptin + Metformin Hydrochloride
|
None
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 March 2024
|
02 February 2028
|
| View |
|
DRP-13376-03
|
Telmisartan + Amlodipine (as besilate)
|
None
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 March 2024
|
08 February 2028
|
| View |
|
DRP-13376-04
|
Telmisartan + Amlodipine (as besilate)
|
Team Duo
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
08 February 2028
|
| View |
|
DRP-13423-02
|
Doxorubicin Hydrochloride
|
Xorugen
|
50 mg
|
Lyophilized Powder for Injection (I.V.)
|
Antineoplastic (Anthracycline)
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
29 March 2024
|
15 February 2028
|
| View |
|
DRP-13471-01
|
Tobramycin (as sulfate)
|
Zartob
|
3 mg per gram (0.3 % w/w)
|
Sterile Opthalmic Ointment
|
Antibacterial (Aminoglycoside)
|
Indiana Ophthalmics
|
India
|
CLIDP Conversion
|
20 March 2024
|
27 February 2028
|
| View |
|
DRP-13517-02
|
Levetiracetam
|
Levetigrand 500
|
500 mg
|
Film-Coated Tablet
|
Anticonvulsant
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
03 March 2028
|
| View |
|
DRP-13518-02
|
Levetiracetam
|
Levetigrand 250
|
250 mg
|
Film-Coated Tablet
|
Anticonvulsant
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 March 2024
|
03 March 2028
|
| View |
|
DRP-13567-02
|
Cefixime (as trihydrate)
|
Fixal
|
100 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Cephalosporin)
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
10 March 2024
|
14 August 2026
|
| View |
|
DRP-13578-01
|
Moxifloxacin (as hydrochloride)
|
None
|
5 mg / mL (0.5 % w/v)
|
Ophthalmic Solution
|
Antiinfective (Fluoroquinolone)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
26 March 2024
|
13 March 2028
|
| View |
|
DRP-13584-01
|
Levetiracetam
|
Levitam 1000
|
1 g
|
Film-Coated Tablet
|
Antiepileptic
|
Zhejiang Jingxin Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
17 March 2024
|
14 March 2028
|
| View |
|
DRP-13585-01
|
Levetiracetam
|
Levitam 500
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
29 March 2024
|
14 March 2028
|
| View |
|
DRP-13595-01
|
Propofol
|
Goprofol
|
10 mg / mL (1% w/v)
|
Emulsion for Intravenous Injection
|
General Anesthethic
|
Dongkook Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
11 March 2024
|
15 March 2028
|
| View |
|
DRP-13673-04
|
Ampicillin (as sodium)
|
Gopicin
|
500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
Uni Medicolabs, Inc
|
India
|
CLIDP Conversion
|
16 March 2024
|
24 March 2028
|